NHLBI Funding Extended for the PETAL Network

Kirsten Kangelaris and investigators at UCSF received continued NHLBI funding for their work in the PETAL (Prevention and Treatment of Acute Lung Injury) Network. PETAL, led by Dr. Michael Matthay, has conducted a series of high-profile clinical trials of sepsis, ARDS, and COVID-19. Recent studies include ROSE, VIOLET, ORCHID, ACTIV-3, ACTIV-4